Anthropic’s new Claude research reveals a hidden internal “global workspace” that resembles human conscious processing, ...
Biohaven Ltd. today announced enrollment of the first patient in the pivotal Phase 3 trial of BHV-1300 for Graves' disease. BHV-1300 is the first MoDE extracellular protein degrader, a novel small ...
Sjögren’s disease (SjD) is a chronic, multisystem autoimmune disorder characterised by lymphocytic infiltration of exocrine ...
An analytical guide to cellular optimization, epigenetic switches, and the daily disciplines that preserve youth from the ...
Otsuka Pharmaceutical Development & Commercialization, Inc. and Otsuka Pharmaceutical Co., Ltd. (Otsuka) today announced positive topline full study results from the Phase 3 VISIONARY trial. VOYXACT ® ...
Morning Overview on MSN
A 100,000-person study links Ozempic-style drugs to lower depression and anxiety
Millions of people taking semaglutide and similar GLP-1 receptor agonists for diabetes or weight loss may also be ...
Explore the evolving landscape of male contraception, including novel nonhormonal pills and injectable hydrogels in clinical ...
The 2026 NFL Draft wide receiver class wasn’t bad by any stretch, but the 2027 NFL Draft group of WRs has a chance to be truly special. Already, there’s a bounty of depth and mid-round potential in ...
CS2009 was designed to restore T-cell effector function, remodel the tumor microenvironment (TME), and enhance T-cell priming via simultaneous targeting of PD-1, VEGF, and CTLA-4, aiming to generate ...
Eisai Co., Ltd. announced today the company will present the latest findings from its Alzheimer’s disease (AD) research, including lecanem ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results